Abbott To Relocate Irish Nutritional Devices Business To Finisklin

Almost €10 million is to be invested by IDA Ireland and global healthcare company Abbott to relocate it's Irish Nutritional Devices business.

The company's existing base at Ballytivnan, Sligo will move to a new, purpose-built IDA Ireland  Advance Technology building located in the Finisklin industrial estate.

The relocation is scheduled to be completed in the first half of 2018, following work to extend the Finisklin building.

Overall, the move will see the consolidation of manufacturing and business support within one building, enabling the creation of a medical nutrition device centre of excellence. In addition, it will provide space for any furuter additional manufacturing and support positions to be created by Abbott.

Making the announcement today, 30 May, Minister for Jobs, Enterprise and Innovation, Mary Mitchell O'Connor TD said: "Abbott's relocation within Sligo to a space with potential for expansion is very positive news for Sligo and the region. Abbott has been a tremendous success story in Ireland with plants located in several regional centres providing valuable employment.

"This move shows Abbott's commitment to Sligo and is a great vote of confidence in what the region has to offer."

Sean O'Hara, Abbott's Site Director at Ballytivnan, said: "Our aim is to enable people to live fuller, healthier lives. The talent available in Ireland is key in enabling us to do so. This relocation and investment ensures our people in Sligo can continue to help people all over the world lead healthier lives full of unlimited possibilities."

CEO of IDA Ireland Martin Shanahan said: "The decision to proactively build properties to attract foreign investors into regional locations has been further evidenced by Abbott Nutrition's decision to move over 100 existing staff members into the newly built IDA Advance Technology building which will also provide scope for the company to grow in the future."

(LM)